Barclays’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.31M Buy
132,487
+36,158
+38% +$1.02M ﹤0.01% 2063
2025
Q4
$3.03M Buy
96,329
+18,658
+24% +$619K ﹤0.01% 2632
2025
Q3
$2.77M Sell
77,671
-47,583
-38% -$2.17M ﹤0.01% 2622
2025
Q2
$7.21M Buy
125,254
+65,328
+109% +$3.69M ﹤0.01% 1810
2025
Q1
$3.49M Sell
59,926
-96,931
-62% -$6.62M ﹤0.01% 2197
2024
Q4
$12.6M Buy
156,857
+78,923
+101% +$6.74M 0.01% 1394
2024
Q3
$6.24M Buy
77,934
+62,599
+408% +$4.45M ﹤0.01% 1885
2024
Q2
$937K Sell
15,335
-22,241
-59% -$1.32M ﹤0.01% 2641
2024
Q1
$1.86M Sell
37,576
-26,813
-42% -$1.28M ﹤0.01% 2634
2023
Q4
$2.7M Buy
64,389
+12,776
+25% +$435K ﹤0.01% 2666
2023
Q3
$1.69M Buy
51,613
+35,746
+225% +$1.22M ﹤0.01% 1995
2023
Q2
$561K Buy
15,867
+2,659
+20% +$87.9K ﹤0.01% 2680
2023
Q1
$375K Buy
13,208
+6,248
+90% +$220K ﹤0.01% 3457
2022
Q4
$289K Buy
6,960
+5,875
+541% +$252K ﹤0.01% 3647
2022
Q3
$45K Sell
1,085
-200
-16% -$7.98K ﹤0.01% 3811
2022
Q2
$42K Buy
1,285
+110
+9% +$4K ﹤0.01% 4099
2022
Q1
$41K Buy
+1,175
New +$28.3K ﹤0.01% 4195

Other funds holding PRCT